{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-061148","form_type":"8-K","ticker":"CAI","cik":"0002019410","company_name":"Caris Life Sciences, Inc.","filed_at":"2025-06-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.691335+00:00","generated_at":"2026-05-19T02:03:19.948946+00:00","sec_items":["5.03","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Caris Life Sciences completes IPO of 23.5M shares at $21.00, raising $494.1M gross","bullets":["IPO of 23,529,412 shares of common stock at $21.00 per share closed June 20, 2025.","Gross proceeds of $494.1 million before underwriting discounts and estimated offering expenses.","Amended and restated certificate of formation and bylaws became effective upon IPO closing.","Shares trade on Nasdaq under ticker CAI."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-061148","json":"https://secwatch.observer/filing/0001104659-25-061148.json","markdown":"https://secwatch.observer/filing/0001104659-25-061148.md","text":"https://secwatch.observer/filing/0001104659-25-061148.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2019410/000110465925061148/0001104659-25-061148-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2019410/000110465925061148/tm2518546d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T02:03:19.948946+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"364008cc69e5269a5b7c2bdfb08697cc78ccaf33","claim":"Caris Life Sciences, Inc.: Amended and Restated Certificate of Formation effective upon closing of IPO (effective 2025-06-20).","evidence_excerpt":"On June 20, 2025, the Amended and Restated Certificate of Formation (the “Certificate of Formation”) of Caris Life Sciences, Inc. (the “Company”), filed with the Secretary of State of the State of Texas on June 10, 2025, and the Amended and Restated Bylaws of the Company (the “Bylaws”) each became effective, in connection with the closing of the initial public offering of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/2019410/000110465925061148/0001104659-25-061148-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-06-20"}],"fact_type":"governance_change"},{"claim_id":"610b0c073d5f6a441cc07b1df91e6c7770522dfd","claim":"Caris Life Sciences, Inc.: Amended and Restated Bylaws effective upon closing of IPO (effective 2025-06-20).","evidence_excerpt":"On June 20, 2025, the Amended and Restated Certificate of Formation (the “Certificate of Formation”) of Caris Life Sciences, Inc. (the “Company”), filed with the Secretary of State of the State of Texas on June 10, 2025, and the Amended and Restated Bylaws of the Company (the “Bylaws”) each became effective, in connection with the closing of the initial public offering of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/2019410/000110465925061148/0001104659-25-061148-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2025-06-20"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}